Clinical trials
Enrolling by invitation Hematologic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| BioMarin Pharmaceutical | 1 |
| Brigham and Women's Hospital | 1 |
| Editas Medicine, Inc. | 1 |
| Fulcrum Therapeutics | 1 |
| Stanford University | 1 |
| Vertex Pharmaceuticals Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 8 |
| Anemia, Sickle Cell | 3 |
| Genetic Diseases, Inborn | 3 |
| beta-Thalassemia | 3 |
| Anemia | 2 |
| Hemoglobinopathies | 2 |
| Anemia, Hemolytic | 1 |
| Anemia, Hemolytic, Congenital | 1 |
| Arrhythmias, Cardiac | 1 |
| Asthma | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.